Invasive Bacterial Disease Surveillance Report Emerging Infections Program Minnesota Department of Health

Similar documents
INVASIVE BACTERIAL DISEASE SURVEILLANCE REPORT, 2010

INVASIVE BACTERIAL DISEASE SURVEILLANCE REPORT, 2016

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*

ANNUAL SUMMARY OF INFECTIOUS DISEASES OHIO 2014

Vaccine Preventable Diseases Surveillance

Utility Debt Securitization Authority 2013 T/TE Billed Revenues Tracking Report

What surveillance do we have for AMR?

Height (ft) Find the average rebound percentage for your ball. Show your work.

2018 HR & PAYROLL Deadlines

Height (ft) Find the average rebound percentage for your ball. Show your work.

Internal Quality Assurance. Jenny Andrews Secretary of the BSAC Working Party on Susceptibility Testing

Key statistics from the National Cardiac Arrest Audit 2016/17

FREEDOM OF INFORMATION REQUEST

Wisconsin 511 Traveler Information Annual Usage Summary January 3, Wisconsin 511 Phone Usage ( )

Bicycle Crashes. Number of Bike Crashes. Total Bike Crashes. are down 21% and severe bike crashes down 8% since 2013 (5 years).

Agricultural Weather Assessments World Agricultural Outlook Board

Agricultural Weather Assessments World Agricultural Outlook Board

GALLUP NEWS SERVICE GALLUP POLL SOCIAL SERIES: WORLD AFFAIRS

GALLUP NEWS SERVICE GALLUP POLL SOCIAL SERIES: WORLD AFFAIRS

GALLUP NEWS SERVICE GALLUP POLL SOCIAL SERIES: WORK AND EDUCATION

National surveillance services a helpful investment in educating healthcare professionals

A review of 2015 fatal collision statistics as of 31 December 2015

Bird strikes Swedish Airspace

SWISS reports stable load factors

MAR DASHBOARD MAR. Compliant % Breakdown Mar % Late % On-time MAR APR MAY JUN JUL AUG SEP OCT NOV DEC

Greater Manchester Police Hate Crime and Hate Incident Data 01/04/14 to 31/03/15

Useful Tools in Mosquito Surveillance

JULY 2013 RIDERSHIP REPORT MTA METRO-NORTH RAILROAD EXECUTIVE SUMMARY

3. EXCEL FORMULAS & TABLES

Bluetongue Disease (BT)

Northland Region road trauma for Northland Region. Road casualties Estimated social cost of crashes* Major road safety issues

MTCF. Michigan Traffic Crash Facts FACT SHEETS

English for Academic Purpose - 20 weeks. ATMC CDU Fed Uni USC. Available Intakes. Orientation Date. English for Academic Purpose - 15 weeks

nipigon.net Township of Nipigon 2018 Community Profile

1. INTRODUCTION 2. THE PURPOSE OF THE USER GUIDE 3. CONTACT 4. INSTRUCTIONS FOR USE. 4.1 How to access the BSAC Resistance Surveillance Database

Little Athletics NSW. 2018/2019 Season. Age Group Information Handbook / 1

1 PEW RESEARCH CENTER

Lake Taneycomo Fisheries Management. Shane Bush : Fisheries Management Biologist

Georgia Annual Health Status Measures 2018

VEHICLE / PEDESTRIAN COLLISIONS

PUBLIC MEETINGS. Please see the City of Geneva Public Meeting Guide for more information regarding City Council and Committee of the Whole meetings.

NCC Cable System Order

The Onychomycosis Market (2018 Edition) September 2018

Supplementary Appendix

SEASONAL PRICES for TENNESSEE FEEDER CATTLE and COWS

NEVADA SLOT MACHINES: HISTORICAL HOLD PERCENTAGE VARIATIONS ANNUAL AND MONTHLY HOLD PERCENTAGES, CENTER FOR GAMING RESEARCH, NOVEMBER 2017

SEPSIS SYMPOSIUM 23 RD INFECTION AND MARCH 2018 SHERATON PORTO CONGRESS COURSES: MAIN TOPICS:

MTCF. Michigan Traffic Crash Facts FACT SHEETS

We All Count: Collaboratively Collecting & Using Biking and Walking Data in Minnesota. Agenda. Why collect info about people biking and walking?

LOS ANGELES UNIFIED SCHOOL DISTRICT DIVISION OF ADULT AND CAREER EDUCATION SAFETY TEST FOR HOSPITAL MAINTENANCE PROGRAM

b Number issued 200,000 (marked with * in the attached appendix) Exercise price is as set out in the appendix

Foreign overnights in the Nordic countries 2015

Osceola County 4-H Record Book Goat Intermediate (10-14)

CME/CPE/MOC Credit Tracker

Rio Grande County Births and Deaths 2015

FOR RELEASE: FRIDAY, MARCH 30 AT 5 AM

MEMORANDUM. City Constituents. Leilani Schwarcz, Vision Zero Surveillance Epidemiologist, SFDPH

3. EXCEL FORMULAS & TABLES

Liberals with steady 10 point lead on Conservatives


Osceola County 4-H Record Book Horse Intermediate (10-14)

Invasive meningococcal disease in the Netherlands

A pheasant researcher notebook:

SWISS Traffic Figures May 2004

September 2018 FY Key Performance Report

MBA Economic and Mortgage Finance Outlook

SEP-1 Additional Notes for Abstraction for Version 5.0b

Alberta Cancer Registry

Nasdaq Dubai AED TRADING HOLIDAYS AND SETTLEMENT CALENDAR 2018 For Equities Outsourced to the DFM (T+2)

Ms. Peggy Gilligan Associate Administrator for Aviation Safety Federal Aviation Administration 800 Independence Avenue, SW Washington, DC 20590

DEC DASHBOARD. Positive Response Compliance DEC. Compliant Tickets : On-Time Performance Analysis. December % Late.

Southern Lodging Summit Memphis, TN. Presented by Randy Smith Founder Smith Travel Research

JAN DASHBOARD. Positive Response Compliance JAN. Compliant Tickets : On-Time Performance Analysis. January % Late.

2017 North Texas Regional Bicycle Opinion Survey

Greater Las Vegas Snapshot by Sale Type Last Month's Sold

May 2018 FY Key Performance Report

Hospitality Outlook Asheville, NC

ALBERTA CANCER REGISTRY

Greater Las Vegas Snapshot by Sale Type Last Month's Sold

Greater Las Vegas Snapshot by Sale Type Last Month's Sold

Greater Las Vegas Snapshot by Sale Type Last Month's Sold

DROWNINGS & OTHER WATER-RELATED INJURIES DURING LAND & AIR TRANSPORT

Veterinary Medical Diagnostic Program

Understanding Rider Differences in Mileage and Riding Frequency through the MSF100 Motorcyclists Naturalistic Study.

January 2019 FY Key Performance Report

September 2017 MLS Statistical Report. Residential Inventory

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:

US Economic Activity

Financial Project ID No(s).: and ETDM No(s).: and 14181

NASDAQ DUBAI TRADING HOLIDAYS AND SETTLEMENT CALENDAR 2018 For Equities Outsourced to the DFM (T+2)

FOR RELEASE: TUESDAY, DECEMBER 11 AT 4 PM

AHFoZ Conference September 2014 ICD 10 Codes - Shane Perumal

Brian Cheuvront, Ph.D. SAFMC Deputy Executive Director for Management

Have You Ever Heard the Phrase

Calendar On US Federal Reserve Holidays, no settlements will take place for USD.

Current Hawaii Economic Conditions. Eugene Tian

Short-Term Transit Ridership and Revenue Forecasting

Farm Energy IQ. Wind Energy on Farms. Objectives of this Module. How windy is it? How windy is it? How windy is it? 2/16/2015

African swine fever in domestic pigs and wild boar (ASF)

Greater Las Vegas Snapshot by Sale Type Last Month's Sold

Transcription:

Invasive Bacterial Disease Surveillance Report 2009 Emerging Infections Program Minnesota Department of Health

Surveillance Methods Cases include Minnesota residents with invasive infections due to Group A Streptococcus, Group B Streptococcus, Haemophilus influenzae, Neisseria meningitidis, Streptococcus pneumoniae and Methicillin- Resistant Staphylococcus aureus (MRSA). Invasive infections are from normally sterile body sites such as blood, cerebrospinal fluid and others. These usually cause serious illnesses (disease). All hospitals and reference laboratories serving Minnesotans are contacted routinely to identify cases.

Surveillance Methods (cont.) Species confirmation, antibiotic resistance and other testing is performed by the MDH Public Health Laboratory. Disease rates are based on census population data. The Centers for Disease Control and Prevention (CDC) includes these results from Minnesota and other states and regions in a network called Active Bacterial Core Surveillance (ABCs) which covers a population base of 41 million.

Incidence of Invasive Group A Streptococcal Disease, Minnesota, 2000-2009 Cases per 100,000 Persons 10 9 8 7 6 5 4 3 2 1 0 4.0 3.6 3.0 2.9 2.9 3.3 3.3 3.5 3.6 2.4 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Year of Diagnosis

Incidence of Invasive Group A Streptococcal Disease by Gender and Age Group, Minnesota, 2009 Characteristic Gender Cases Incidence per 100,000 Persons Male 111 4.3 Female 78 3.0 Age Group Under 1 yr. 6 8.2 1-4 yrs. 13 4.6 5-9 yrs. 11 3.3 10-19 yrs. 10 1.4 20-29 yrs. 15 2.1 30-39 yrs. 22 3.3 40-49 yrs. 17 2.1 50-59 yrs. 31 4.3 60-69 yrs. 24 5.5 70+ yrs. 40 8.7

Invasive Group A Streptococcal Disease Cases and Deaths by Age Group, Minnesota, 2009 Age Group Cases Deaths % Died Under 1 yr. 6 1 17% 1-4 yrs. 13 0 0% 5-9 yrs. 11 0 0% 10-19 yrs. 10 0 0% 20-29 yrs. 15 1 7% 30-39 yrs. 22 2 9% 40-49 yrs. 17 1 6% 50-59 yrs. 31 3 10% 60-69 yrs. 24 3 13% 70+ yrs. 40 10 25% Total 189 21 11%

Invasive Group A Streptococcal Disease by Type of Infection, Minnesota, 2009 Abscess 10% Multiple infections 10% Bacteremia without another infection (blood) 31% Meningitis (brain/spinal cord) 1% Necrotizing fasciitis (deep tissue) 3% Pneumonia (lung) 8% Cellulitis (skin) 14% Other 23%

Outcome of Invasive Group A Streptococcal Disease Cases by Type of Infection, Minnesota, 2009 Died Survived 100 90 80 70 Percentage 60 50 40 30 20 10 0 Necrotizing fasciitis Pneumonia Bacteremia without another infection Meningitis Cellulitis Other Multiple infections Type of Infection

40 35 Cases of Invasive Group A Streptococcal Disease by Month of Culture and Outcome Minnesota, 2009 Number of Cases 30 25 20 15 10 5 Died Survived 0 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Month of Culture

Cases of Invasive Group A Streptococcal Disease by Month of Culture and Outcome Minnesota, 2008 2009 40 35 Number of Cases 30 25 20 15 10 Died Survived 5 0 Jan Mar May Jul Sep Nov Jan Mar May Jul Sep Nov Month of Culture 2008 2009

Incidence of Invasive Group B Streptococcal Disease Minnesota, 2000-2009 Cases per 100,000 Persons 10.0 9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 8.7 8.0 6.7 7.0 6.0 6.2 6.5 6.5 6.4 5.5 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Year of Diagnosis

Incidence of Invasive Group B Streptococcal Disease by Gender and Age Group, Minnesota, 2009 Characteristic Gender Cases Incidence per 100,000 persons Male 240 9.3 Female 214 8.2 Age Group Under 1 yr. 39 53.0 1-4 yrs. 0 0 5-9 yrs. 0 0 10-19 yrs. 2 0.3 20-29 yrs. 16 2.2 30-39 yrs. 23 3.4 40-49 yrs. 37 4.6 50-59 yrs. 79 11.0 60-69 yrs. 102 23.2 70+ yrs. 156 33.7

Invasive Group B Streptococcal Disease Cases and Deaths by Age Group, Minnesota, 2009 Age Group Cases Deaths % Died Under 1 yr. 39 1 3% 1-4 yrs. 0 0 -- 5-9 yrs. 0 0 -- 10-19 yrs. 2 0 0% 20-29 yrs. 16 0 0% 30-39 yrs. 23 1 4% 40-49 yrs. 37 0 0% 50-59 yrs. 79 1 1% 60-69 yrs. 102 6 6% 70+ yrs. 156 16 10% Total 454 25 6%

Invasive Group B Streptococcal Disease by Type of Infection, Minnesota, 2009 Septic arthritis (joint) 5% Meningitis (brain/spinal cord) 2% Multiple Infections 2% Osteomyelitis (bone) 9% Bacteremia without another infection (blood) 45% Pneumonia (lung) 8% Other 14% Cellulitis (skin) 15%

Neonatal Sepsis-Invasive Disease in First Six Days of Life by Pathogen, Minnesota, 2009 Other 9% Salmonella spp. 2% Group A Strep. 2% H. influenzae 11% Group B Strep. 36% S. viridians 16% E. coli 24%

0.7 Incidence of Invasive Early and Late Onset Group B Streptococcal Disease, Minnesota, 2000-2009 Cases per 1,000 Live Births 0.6 0.5 0.4 0.3 0.2 0.1 0.49 0.34 0.33 0.26 0.40 0.26 EO (infection at 0-6 days of life) LO (infection at 7-89 days of life) 0.38 0.36 0.29 0.31 0.32 0.29 0.25 0.24 0.26 0.31 0.18 0.22 0.22 0.22 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Year of Diagnosis

Early Onset* Group B Streptococcal Disease by Race, Gestational Age and Survival, Minnesota, 2009 Characteristic Number Percent Race White Black Other Gestational Age Under 32 weeks 32-37 weeks Full term Outcome Died * Onset 0-6 Days of Life 11 Survived 16 Total Cases 16 2 3 3 5 8 0 69% 12% 19% 19% 31% 50% -- 100%

Cases of Invasive Group B Streptococcal Disease by Month of Culture and Outcome, Minnesota, 2009 60 50 Died Survived Number of Cases 40 30 20 10 0 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Month of Culture

Cases of Invasive Group B Streptococcal Disease by Month of Culture and Outcome, Minnesota, 2008 2009 60 50 Died Survived Number of Cases 40 30 20 10 0 Jan Mar May Jul Sep Nov Jan Mar May Jul Sep Nov 2008 Month of Culture 2009

Incidence of Invasive Haemophilus influenzae Disease, Minnesota, 2000-2009 4 Cases per 100,000 Persons 3 2 1 1.1 1.1 1.0 1.1 1.1 1.0 1.9 1.6 1.4 1.5 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Year of Diagnosis

Incidence of Invasive Haemophilus influenzae Disease by Gender and Age Group, Minnesota, 2009 Characteristic Gender Cases Incidence per 100,000 persons Male 31 1.2 Female 48 1.8 Age Group Under 1 yr. 7 9.5 1-4 yrs. 5 1.8 5-9 yrs. 1 0.3 10-19 yrs. 3 0.4 20-29 yrs. 0 -- 30-39 yrs. 3 0.4 40-49 yrs. 4 0.5 50-59 yrs. 8 1.1 60-69 yrs. 12 2.7 70+ yrs. 36 7.8

Invasive Haemophilus influenzae Disease Cases and Deaths by Age Group, Minnesota, 2009 Age Group Cases Deaths % Died Under 1 yr. 7 0 0% 1-4 yrs. 5 1 20% 5-9 yrs. 1 0 0% 10-19 yrs. 3 1 33% 20-29 yrs. 0 -- -- 30-39 yrs. 3 0 0% 40-49 yrs. 4 1 25% 50-59 yrs. 8 1 13% 60-69 yrs. 12 2 17% 70+ yrs. 36 3 8% Total 79 9 11%

Invasive Haemophilus influenzae Disease by Type of Infection, Minnesota, 2009 Epiglottitis (throat) 3% Meningitis (brain/spinal cord) 3% Multiple infections 1% Other 10% Peritonitis (abdomen) 5% Pneumonia (lung) 41% Bacteremia without another infection (blood) 38%

Invasive Haemophilus influenzae Disease by Serotype, Minnesota, 2009 Serotype f 10% Serotype e 1% Serotype b 3% Serotype a 7% Non-typeable 79%

Cases of Invasive H. influenzae Disease by Month of Culture, Serotype and Outcome, Minnesota, 2009 Number of Cases 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1 Type b Non Type b Death Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2009 Month of Culture

Cases of Invasive H. influenzae Disease by Month of Culture Serotype and Outcome, Minnesota, 2008 2009 Number of Cases 16 15 Type b 14 Non Type b 13 Death 12 11 10 9 8 7 6 5 4 3 2 1 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2008 2009 Month of Culture

Incidence of Invasive Neisseria meningitidis Disease, Minnesota, 2000-2009 4 Cases per 100,000 Persons 3 2 1 0.45 0.54 0.72 0.57 0.47 0.31 0.29 0.31 0.57 0.31 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Year of Diagnosis

Incidence of Invasive Neisseria meningitidis Disease by Gender and Age Group, Minnesota, 2009 Characteristic Gender Cases Incidence per 100,000 persons Male 6 0.23 Female 10 0.38 Age Group Under 1 yr. 3 4.08 1-4 yrs. 2 0.70 5-9 yrs. 0 -- 10-19 yrs. 3 0.42 20-29 yrs. 2 0.27 30-39 yrs. 1 0.15 40-49 yrs. 1 0.13 50-59 yrs. 2 0.28 60-69 yrs. 1 0.23 70+ yrs 1 0.22

Invasive Neisseria meningitidis Disease Cases and Deaths by Age Group, Minnesota, 2009 Age Group Cases Deaths % Died Under 1 yr. 3 0 0% 1-4 yrs. 2 0 0% 5-9 yrs. 0 -- -- 10-19 yrs. 3 0 0% 20-29 yrs. 2 0 0% 30-39 yrs. 1 0 0% 40-49 yrs. 1 0 0% 50-59 yrs. 2 0 0% 60-69 1 70+ yrs. 1 0 0% Total 16 1 6% 1 100%

Invasive Neisseria meningitidis by Type of Infection, Minnesota, 2009 Septic Arthritis (joint) 6% Pneumonia (lung) 12% Bacteremia without another infection (blood) 19% Meningitis (brain/spinal cord) 63%

Cases of Invasive Neisseria meningitidis Disease by Month of Culture, Serogroup and Outcome, Minnesota, 2009 Serogroup B Number of Cases 5 4 3 2 1 Jan Serogroup C Serogroup Y Death Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2009 Month of Culture

Cases of Invasive Neisseria meningitidis Disease by Month of Culture, Serogroup and Outcome, Minnesota, 2008 2009 16 15 Number of Cases 14 13 12 11 10 9 8 7 6 5 4 3 2 1 Serogroup B Serogroup C Serogroup Y Serogroup Z Serogroup W135 Death Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2008 2009 Month of Culture

Incidence of Invasive Pneumococcal Disease Minneapolis-St. Paul Metropolitan Area, 2000-2001 and Minnesota, 2002-2009 25 Cases per 100,000 Persons 20 15 10 5 16.6 12.7 11.9 12.3 12.8 13.6 12.0 10.6 11.6 13.1 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Year of Diagnosis

Incidence of Invasive Pneumococcal Disease by Gender and Age Group, Minnesota, 2009 Characteristic Gender Cases Incidence per 100,000 persons Male 359 13.8 Female 327 12.5 Age Group Under 1 yr. 32 43.5 1-4 yrs. 66 23.2 5-19 yrs. 36 3.5 20-29 yrs. 26 3.6 30-39 yrs. 39 5.8 40-49 yrs. 132 16.6 50-64 yrs. 116 12.0 65-79 yrs. 131 29.2 80+ yrs. 108 53.4

Invasive Pneumococcal Disease Cases and Deaths by Age Group, Minnesota, 2009 Age Group Cases Deaths % Died Under 1 yr. 32 2 6% 1-4 yrs. 66 2 3% 5-19 yrs. 36 2 6% 20-29 yrs. 26 2 8% 30-39 yrs. 39 3 8% 40-49 yrs. 132 7 5% 50-64 yrs. 116 12 10% 65-79 yrs. 131 10 8% 80+ yrs. 108 24 22% Total 686 64 9%

Invasive Pneumococcal Disease by Type of Infection, Minnesota, 2009 Meningitis (brain/spinal cord) 4% Other 4% Multiple Infections 2% Bacteremia without another infection (blood) 33% Pneumonia (lung) 58%

Invasive Pneumococcal Isolates by Serotype Included in 13 Valent Conjugate Vaccine* by Age Group, Minnesota, 2009 Age Group Isolates # Included in PCV 13 % Included in PCV 13 Under 1 yr. 31 21 68% 1-4 yrs. 64 45 70% 5-19 yrs. 30 23 77% 20-29 yrs. 24 14 58% 30-39 yrs. 38 19 50% 40-49 yrs. 118 66 56% 50-64 yrs. 111 68 61% 65-79 yrs. 125 66 53% 80+ yrs. 98 42 43% Total 639 364 57% *Serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 23F

Invasive Pneumococcal Isolates by Resistance to Antimicrobial Agents, Minnesota, 2009 Penicillin resistance (R)* Meningitis breakpoints Non-meningitis breakpoints Total Resistant Isolates 153 7 % Resistant Isolates 24% 1% Resistance to drug classes** R to 1 drug class R to 2-3 drug classes R to 4-6 drug classes 81 52 84 13% 8% 13% Total Isolates 639 34% * Isolates with MIC > 0.12 μg/ml are Penicillin-R for meningitis, > 8 μg/ml for non-meningitis. ** Eleven drug classes assessed; R to beta-lactams was assessed by penicillin MIC > 0.12 μg/ml.

Cases of Invasive Pneumococcal Disease by Month of Culture and Outcome, Minnesota, 2009 100 90 80 Survived Died Number of Cases 70 60 50 40 30 20 10 0 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Month of Culture

Cases of Invasive Pneumococcal Disease by Month of Culture and Outcome Minnesota, 2008 2009 Number of Cases 100 90 80 70 60 50 40 30 20 10 0 Died Survived Jan Mar May Jul Sep Nov Jan Mar May Jul Sep Nov Month of Culture 2008 2009

Incidence of Invasive MRSA Disease Ramsey and Hennepin Counties*, Minnesota, 2004-2009 25 Cases per 100,000 Persons 20 15 10 5 11.9 19.8 19.4 20.9 20.3 17.1 0 2004 2005 2006 2007 2008 2009 Year of Diagnosis * Data from years 2004-2007 includes Ramsey County only.

Incidence of Invasive MRSA Disease by Gender and Age Group, Ramsey and Hennepin Counties, Minnesota, 2009 Characteristic Gender Cases Incidence per 100,000 persons Male 171 21.1 Female 111 13.2 Age Group Under 1 yr. 2 8.5 1-4 yrs. 3 3.2 5-9 yrs. 3 2.8 10-19 yrs. 1 0.5 20-29 yrs. 13 6.3 30-39 yrs. 12 5.1 40-49 yrs. 34 13.1 50-59 yrs. 54 23.0 60-69 yrs. 58 42.3 70+ yrs. 101 75.2

Invasive MRSA Disease Cases and Deaths by Age Group, Ramsey and Hennepin Counties, Minnesota, 2009 Age Group Cases Deaths % Died Under 1 yr. 2 0 0% 1-4 yrs. 3 1 33% 5-9 yrs. 3 0 0% 10-19 yrs. 1 0 0% 20-29 yrs. 13 0 0% 30-39 yrs. 12 0 0% 40-49 yrs. 34 1 3% 50-59 yrs. 54 5 9% 60-69 yrs. 58 9 16% 70+ yrs. 101 19 19% Total 281 35 12%

Incidence of Invasive MRSA Disease by Case Type, Ramsey and Hennepin Counties, Minnesota, 2009 Case Type Cases Incidence per 100,000 persons Healthcare-associated 242 14.7 Community-associated 38 2.3 Healthcare-associated if case had one or more of the following: MRSA infection was identified more than 3 days after hospital admission; history of hospitalization, surgery, dialysis or residence in a long-term care facility in the previous year; or, presence of an indwelling catheter. Community-associated: none of the previously mentioned criteria were met.

Invasive MRSA Disease by Type of Infection Ramsey and Hennepin Counties, Minnesota, 2009 Type of Infection* Cases Bacteremia (blood) 166 Without another source of infection 90 With another source of infection 76 Pneumonia (lung) 35 Osteomyelitis (bone) 41 Cellulitis (skin) 14 Endocarditis (heart) 3 More than one infection type 102 Other infection** 34 * Cases may have had more than 1 type of infections ** Other infections included urinary tract, internal organ abscess, empyema (pus), septic arthritis (joint), meningitis (brain/spinal cord)